Fda Fast Track (original) (raw)

Latest News for: fda fast track

Matisse obtains FDA Fast Track Designation for isupartob sodium in sepsis. FDA's Fast Track is designed to get important new drugs to the patient earlier ... .

Edit

Matisse Pharmaceuticals receives FDA Fast Track Designation for isupartob sodium in sepsis (Brightlands Venture Partners BV)

Public Technologies 09 Jun 2026

Food and Drug Administration (FDA) has granted Fast Track Designation for its lead compound isupartob sodium ... [...]. This is an abstract of the document ... Disclaimer ... (noodl.

Edit

GFH375/VS-7375 Granted with FDA's Fast Track Designation for Treatment of KRAS G12D-mutant Unresectable Locally Advanced or Metastatic NSCLC (Apricot Capital)

Public Technologies 08 Jun 2026

Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to GFH375/VS-7375 for the treatment of adult patients with KRAS G12D-mutated unresectable locally advanced ...

Edit

Verastem Oncology Announces U.S. FDA Fast Track Designation for VS-7375, an Oral and Potential Best-in-Class ...

Business Wire 04 Jun 2026

BOSTON--(BUSINESS WIRE)---- $VSTM #CRC--FDA grants Fast Track designation to VS-7375, an oral investigational KRAS G12D inhibitor, for locally advanced or metastatic KRAS G12D-mutated NSCLC ... .

Edit

Terremoto Biosciences Granted FDA Fast Track Designation for TER-2013, an AKT1-Selective Small Molecule Inhibitor for ...

Business Wire 03 Jun 2026

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Terremoto Biosciences Granted FDA Fast Track Designation for TER-2013, an AKT1-Selective Small Molecule Inhibitor for Breast Cancer ... .

Edit

Nouscom Receives U.S. FDA Fast Track Designation for NOUS-209, a Novel Immunotherapy for the Prevention ...

Nasdaq Globe Newswire 01 Jun 2026

Nouscom receives FDA Fast Track Designation for NOUS-209, advancing development of its cancer-prevention immunotherapy for Lynch Syndrome carriers ... .

Edit

Solu Therapeutics Granted FDA Fast Track Designation for STX-0712 for Treatment of Chronic Myelomonocytic Leukemia

The Buffalo News 28 May 2026

Food and Drug Administration (FDA) has granted Fast Track ...

Edit

Autobahn Therapeutics Announces U.S. FDA Fast Track Designation for Elunetirom, a CNS-Directed Thyroid Hormone Receptor ...

The Eagle-Tribune 26 May 2026

SAN DIEGO--(BUSINESS WIRE)--May 26, 2026-- ... .

Edit

INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer's Disease

Nasdaq Globe Newswire 14 May 2026

Food and Drug Administration (FDA) has granted Fast Track designation to XPro™ (pegipanermin), the company's first-in-class ...

Edit

INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer’s Disease (Form 8-K) (INmune Bio Inc)

Public Technologies 14 May 2026

INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer's Disease ... "Phase 2 MINDFuL data, our End-of-Phase 2 alignment with FDA, and now Fast Track designation reflects a consistent regulatory and scientific case.

Edit

Coya Therapeutics Has Been Granted U.S. FDA Fast Track Designation for COYA 302 for the ...

Hastings Tribune 12 May 2026

HOUSTON--(BUSINESS WIRE)--May 12, 2026-- ... .

Edit

Zai Lab Receives U.S. FDA Fast Track Designation for Zocilurtatug Pelitecan (Zoci), a DLL3-Targeting ADC, ...

The Galveston Daily News 11 May 2026

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 11, 2026-- ....

Edit

Sironax’s SARM1 Inhibitor SIR2501 Granted FDA Fast Track Designation in Chemotherapy-induced Peripheral Neuropathy (CIPN)

Nasdaq Globe Newswire 11 May 2026

CIPN is a common nerve-damaging side effect of chemotherapy with no FDA-approved treatment options ... .

Edit

Armata Pharmaceuticals Secures FDA Fast Track Designation for AP-SA02 (Form 8-K) (Armata Pharmaceuticals Inc)

Public Technologies 07 May 2026

Armata Pharmaceuticals Secures FDA Fast Track Designation for AP-SA02 ... Food and Drug Administration (the "FDA") has granted Fast Track Designation to AP-SA02, the Company's intravenously administered Staphylococcus aureus ("S.